NPI registry status
Active
2026 NPPES data Cardiovascular Disease Physician NPI 1356360887 MD
Verify on CMS → Afshine Emrani, MD
Cardiovascular Disease Physician in Tarzana, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 24,810 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
35K
Medicare Part D claims · 1K beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
63%
generic claims · 37% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.6/100
▲ 16 pts above national avg 83.1 · Exceptional
Industry payments
$4.5K
178 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Afshine Emrani, MD reported a CMS MIPS final score of 98.6/100 - above the 83.1 national average - and filed 35,136 Medicare Part D claims in 2023.
- 98.6/100
- MIPS score · +16 vs avg
- 35K
- Part D claims, 2023
- 63%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Afshine Emrani, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
99 Top 11% higher than 89% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Afshine Emrani, MD sits
This provider among cardiovascular disease physician peers
Across the 8,753 cardiovascular disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Afshine Emrani, MD writes more Part D claims than 100% of them and scores higher on MIPS quality than 89% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one cardiovascular disease physician peer from a representative sample of 60; the gold marker is Afshine Emrani, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Afshine Emrani, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Afshine Emrani, MD?
High performer (top quartile)Primary specialty
Cardiovascular Disease Physician
Medicare Part D claims
35,136 12× vs specialty avg
MIPS final score
98.6/100 15.5 pts vs avg
Specialty distribution in California
How Cardiovascular Disease Physician compares to other specialties among California providers
Medicare quality performance, MIPS
Afshine Emrani, MD's 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 98.6/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cardiovascular Disease Physician) - 98.6/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Afshine Emrani, MD appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding MD credentials at 18370 BURBANK BLVD, Tarzana, CA, 91356, with a listed phone of (818) 996-4100. NPI 1356360887 was issued on 07/18/2006.
Medicare Part D records for calendar year 2023 show 35,136 prescription claims written by this provider, covering 1,306 Medicare beneficiaries and totaling roughly $11.4 million in drug spend, split 37% brand-name and 63% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.6/100 for the 2023 performance year (Quality 87.2), compared with the national average of 83.1.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,810 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1356360887 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/18/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
98.6152
Final Score
Avg: 83.1
87.2304
Quality
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Afshine Emrani, MD. Source: openpaymentsdata.cms.gov.
Total received
$4.5K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Afshine Emrani, MD. To verify Afshine Emrani, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Afshine Emrani, MD - brand share 37.0%
Cardiovascular Disease Physician average
37% brand-name claims vs 63% generic, on 35,136 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
35,136
Total Claims
$11.4M
Total Drug Cost
1,306
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 62,775
- Total Day Supply
- 1,855,185
- Brand vs Generic
- 37% brand / 63% generic
- Brand Drug Cost
- $9.8M
- Generic Drug Cost
- $1.6M
- Antibiotic Claims
- 512
Patient Demographics
- Average Patient Age
- 76.5 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 41, 65-74: 518, 75-84: 518, 85+: 229
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Afshine Emrani, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Vascepa
Vascepa
2,010 claims
- Repatha Sureclick
Repatha Sureclick
1,150 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
1,042 claims
- Amlodipine Besylate
Amlodipine Besylate
1,032 claims
- Atorvastatin Calcium
Atorvastatin Calcium
929 claims
- Metoprolol Succinate
Metoprolol Succinate
914 claims
- Olmesartan Medoxomil
Olmesartan Medoxomil
831 claims
- Levothyroxine Sodium 756
Levothyroxine Sodium
756 claims
| Drug | Claims |
|---|---|
| Vascepa Icosapent Ethyl | 2,010 |
| Repatha Sureclick Evolocumab | 1,150 |
| Rosuvastatin Calcium | 1,042 |
| Amlodipine Besylate | 1,032 |
| Atorvastatin Calcium | 929 |
| Metoprolol Succinate | 914 |
| Olmesartan Medoxomil | 831 |
| Levothyroxine Sodium | 756 |
| Clopidogrel Clopidogrel Bisulfate | 709 |
| Escitalopram Oxalate | 678 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How Afshine Emrani, MD fits within the Cardiovascular Disease Physician landscape nationally.
24,810
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider
Afshine Emrani, MD's 35,136 claims are above the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Emrani.
Dr. Abdul Abbasi
MD
Long Beach, CA
Dr. Lillian Abdelmalek
MD
Sacramento, CA
Dr. Robin Abdelmalik
M.D. FACC
Temecula, CA
Dr. Roberto Abdelnur
MD
El Centro, CA
Dr. Sohail Abdi-Moradi
M.D.
Moorpark, CA
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Cardiovascular Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Afshine Emrani, MD's specialty? ▼
Afshine Emrani, MD specializes in Cardiovascular Disease Physician and practices in Tarzana, California. Credentials: MD.
How much does Afshine Emrani, MD prescribe under Medicare Part D? ▼
In 2023, Afshine Emrani, MD wrote 35,136 Medicare Part D claims totaling $11.4M in drug costs for 1,306 beneficiaries.
What is Afshine Emrani, MD's Medicare quality score? ▼
Afshine Emrani, MD has a CMS MIPS Final Score of 98.6/100 (Quality: 87.2). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Afshine Emrani, MD located? ▼
Afshine Emrani, MD is located at 18370 BURBANK BLVD, Tarzana, CA, 91356. Phone: (818) 996-4100.
What is Afshine Emrani, MD's NPI number? ▼
Afshine Emrani, MD's National Provider Identifier (NPI) is 1356360887, issued on 07/18/2006.
Does Afshine Emrani, MD prescribe more brand-name or generic drugs? ▼
Afshine Emrani, MD's prescribing is 37% brand-name and 63% generic drugs by claim count, with $9.8M in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US? ▼
There are 24,810 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does Afshine Emrani, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Afshine Emrani, MD's most frequently prescribed drugs include Vascepa, Repatha Sureclick, Rosuvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Afshine Emrani, MD accept Medicare? ▼
Afshine Emrani, MD appears in CMS Medicare data with 35,136 Part D claims and 1,306 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Afshine Emrani, MD's credentials? ▼
Afshine Emrani, MD's NPI is 1356360887 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.